Evidence map›Paper›PMID 35563665›Full record

ArticleInternational journal of molecular sciences2022

AOM/DSS Induced Colitis-Associated Colorectal Cancer in 14-Month-Old Female Balb/C and C57/Bl6 Mice-A Pilot Study.

Martin Schepelmann, Nadja Kupper, Valeriya Gushchina, Ildiko Mesteri, Teresa Manhardt, Stefan Moritsch, Christian Müller, Karina Piatek, Martina Salzmann, Andrea Vlasaty and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Martin SchepelmannInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7017-5426
Nadja KupperInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6497-024X
Valeriya GushchinaInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9773-1808
Ildiko MesteriPathologie Überlingen, 88662 Überlingen, Germany.ORCID 0000-0002-2831-8147
Teresa ManhardtInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Stefan MoritschCenter for Cancer Research, Medical University of Vienna, 1090 Vienna, Austria.
Christian MüllerInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Karina PiatekInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Martina SalzmannInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Andrea VlasatyInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Robert EferlCenter for Cancer Research, Medical University of Vienna, 1090 Vienna, Austria.
Enikö KallayInstitute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-4996-0104
Medical University of Vienna · ATComprehensive Cancer Center Vienna · ATAkademie Überlingen (Germany) · DE

Funding

Austrian Science Fund FWF P 29948FWF Austrian Science Fund DOC 59-833FWF Austrian Science Fund P 29948-B28FWF Austrian Science Fund P35069-BFWF Austrian Science Fund & Herzfelder Family Foundation P 32840-B
6 · The paper itself

Abstract

Colitis is a major risk factor for the development of colorectal cancer, leading to colitis-associated colorectal cancer (CAC). The most commonly used animal model to study CAC is the azoxymethane-dextran sulphate-sodium (AOM/DSS) model. The ideal experimental conditions of this model depend on several factors, including the used mouse strain. No data on feasibility and conditions for older mice, e.g., for aging studies, have yet been reported. Thus, we conducted a descriptive, observational pilot study where CAC was induced in 14-month-old female Balb/C and C57/Bl6 mice using 12.5 mg/kg AOM i.p. and three different concentrations of DSS (1, 2, and 3%) in drinking water (ad. lib.). The mice were monitored regularly during the three-month experimental phase. After euthanasia, the colons of the mice were evaluated macroscopically and microscopically. Both the mouse strains showed a DSS-concentration-dependent induction of CAC. Carcinomas were only observed at 3% DSS. The DSS dose was found to be significantly correlated with the histology score and % Ki67 positive cells only in C57/Bl6 mice but not in Balb/C mice, which showed a variable response to the CAC induction. No differences in colon length, weight, or mucin content were observed. Optimal conditions for CAC induction in these aged animals are thus considered to be 3% DSS, as carcinomas did not develop when 2% DSS was used. On the other hand, Balb/C mice reacted severely to 3% DSS, indicating that 2.5% DSS may be the "sweet spot" for future experiments comparing CAC in aged Balb/C and C57/Bl6 mice. This model will allow investigation of the effect of aging on CAC development and therapy.

Indexed as

CarcinomaColitisColitis-Associated NeoplasmsColorectal NeoplasmsAnimalsAzoxymethaneCarcinogenesisDextran SulfateDisease Models, AnimalFemaleMiceMice, Inbred BALB CMice, Inbred C57BLPilot ProjectsAzoxymethaneDextran Sulfateaged miceAOMcolitis associated colorectal cancerDSSmouse strain differencespilot study

Identifiers

PMID35563665
PMCPMC9104960
OpenAlexW4229458897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.